Nasal Mucosa Drug Supply Device Market Trends

Key Emerging Trends in the Nasal Mucosa Drug Supply Device Market

Increasing Incidence of Asthma

Asthma is a persistent lung ailment characterized by inflammation and the narrowing of bronchial tubes, the pathways that let air in and out of the lungs. It can affect people of all ages but often begins in childhood. Asthma is a leading cause of hospitalization, especially for kids under five years old. The World Health Organization (WHO) reported that around 235 million people worldwide had asthma in December 2016. This condition brings about various symptoms like coughing, shortness of breath, chest tightness, wheezing, and variable airflow restriction during exhalation. Triggers for these symptoms include exercise, exposure to allergens or irritants, changes in weather, and viral respiratory infections. Asthma is particularly widespread among children and is not limited to high-income countries; it occurs globally. Shockingly, more than 80% of asthma-related deaths take place in low and lower-middle-income countries.

Furthermore, the Global Asthma Report 2018 reveals that asthma claims the lives of approximately 1000 people daily. While asthma cannot be completely cured, its effects can be managed effectively. Inhaler devices play a crucial role in this management, contributing to the growth of the asthma inhaler device market.

Growing Demand for Emergency Medication

The unpredictability of asthma attacks significantly contributes to the rising popularity of inhaler devices. Inhalers are convenient and easy to use during sudden asthma attacks. International guidelines recommend the use of inhaled β2-agonists for quick relief in asthma patients. Consequently, these unpredictable attacks and respiratory emergencies are key factors driving the increased use of inhalers today. Disturbingly, nearly 70% of annual deaths in children result from respiratory disorders and sudden attacks. In such critical situations, rescue medication or rescue inhalers can play a vital role in saving many lives each year. Children with asthma are particularly vulnerable to these unforeseen attacks. In these circumstances, inhalers emerge as the most accessible and effective devices, contributing to the expansion of the asthma inhaler device market.

In conclusion, the prevalence of asthma is on the rise globally, affecting millions of people. This chronic lung condition, especially common in children, leads to hospitalizations and poses a significant public health challenge. Despite its incurable nature, effective management is possible, with inhaler devices playing a crucial role. The growing need for emergency medication, especially during unpredictable asthma attacks, further propels the use of inhalers, saving lives and driving the growth of the asthma inhaler device market. As efforts continue to raise awareness and improve access to these essential devices, the hope is to mitigate the impact of asthma and enhance the quality of life for those affected.